In a paper just published online in the journal Cancer Research, the researchers found high concentrations of specific proteins that point to alterations in three sequences of chemical reactions known as biochemical pathways of mice implanted with human kidney cancer cells. The findings suggest that cancerous tumors modulate the pathways, which in turn makes these pathways potential therapeutic targets.
Nicotinamide and cinnamoylglycine, which were altered as a signature of one of the pathways, are just two of approximately 2,000 chemicals, or metabolites, that the human body produces. Metabolites, referring to any substance produced by metabolism, are a reflection of the body's processes in real time. The field of study, known as metabolomics, enables researchers to discover biomarkers and to identify novel therapeutic targets.
The study used metabolomics techniques and instrumentation to simultaneously examine chemicals in two biofluids (urine and serum, or blood) as well as tissue from kidney cancer mice models. Seeking to describe the utility of these fluids as tumor indicators, they found that serum metabolomics analysis is the most accurate proxy of chemical changes that are related to kidney cancer.
"It's exciting to report that our identification of several important metabolic processes may well result in the discovery of diagnostic markers and new therapeutic targets for kidney cancers," said lead author Robert H. Weiss, a professor in the UC Davis Division of Nephrology, Department of Internal Medicine. Currently, there are no tests to easily identify kidney cancer and current treatments are not always successful, so these markers will be important tools for detection and new treatments of the disease.
For the study, researchers transplanted human kidney cancer cells into a mouse model capable of growing human tumors. Researchers compared the metabolites identified in the implanted mice against those in a control group of mice that had surgery, but no cancer cells implanted.
If further research with mouse models demonstrates that inhibition of the newly identified targets works in therapy, then preparation for human trials will be a next step.
"This research represents collaboration among many kinds of experts, all of whom are concerned that kidney cancer patients have too few treatment options, which often have debilitating side effects," said Weiss, who serves as chief of nephrology at the Sacramento Veterans' Administration Medical Center in addition to his work at UC Davis.
The research was funded by the National Institutes of Health and the Medical Service of the U.S. Department of Veterans' Affairs, grants 1R01CA135401-01A1 and 1R01DK082690-01A1. Other UC Davis authors were Sheila Ganti and Omran Abu Aboud of the Department of Internal Medicine, Sandra L. Taylor and Kyoungmi Kim of the Department of Public Health Sciences, Joy Yang of the Department of Urology, and Christopher Evans of the Comprehensive Cancer Center and Department of Urology. Authors also included Michael V. Osier of the Rochester Institute of Technology and Danny C. Alexander of Metabolon in Durham, N.C.UC Davis Comprehensive Cancer Center
Its innovative research program engages more than 280 scientists at UC Davis, Lawrence Livermore National Laboratory and Jackson Laboratory (JAX West), whose scientific partnerships advance discovery of new tools to diagnose and treat cancer. Through the Cancer Care Network, UC Davis collaborates with a number of hospitals and clinical centers throughout the Central Valley and Northern California regions to offer the latest cancer care. Its community-based outreach and education programs address disparities in cancer outcomes across diverse populations.
Further reports about: > Cancer > Comprehensive Cancer Center > Internal Medicine > Researchers > Rift Valley Fever > biochemical pathway > cancer cells > cancerous tumor > chemical reaction > diagnostic marker > education program > health services > kidney cancer > metabolic process > mouse model > specific protein > therapeutic targets
A new approach to targeting cancer cells
20.05.2019 | University of California - Riverside
Radioisotope couple for tumor diagnosis and therapy
14.05.2019 | Kanazawa University
Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...
With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.
Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...
'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.
However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...
Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future
When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...
Scientists develop a molecular recording tool that enables in vivo lineage tracing of embryonic cells
The beginning of new life starts with a fascinating process: A single cell gives rise to progenitor cells that eventually differentiate into the three germ...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
21.05.2019 | Physics and Astronomy
21.05.2019 | Earth Sciences
21.05.2019 | Life Sciences